RJ, E., LJ, T., & YF, G. (2021). 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology. Journal of oncology, 2021, 9955456. https://doi.org/10.1155/2021/9955456
Chicago Style (17th ed.) CitationRJ, Epstein, Tian LJ, and Gu YF. "2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology." Journal of Oncology 2021 (2021): 9955456. https://doi.org/10.1155/2021/9955456.
MLA (9th ed.) CitationRJ, Epstein, et al. "2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology." Journal of Oncology, vol. 2021, 2021, p. 9955456, https://doi.org/10.1155/2021/9955456.
Warning: These citations may not always be 100% accurate.